Eikon Therapeutics (EIKN) Short Interest
Nasdaq • EIKN • US2825641036
As of Oct 27, 2026, ORTEX estimated 18.2% of free float sold short, 11.7 days to cover, cost to borrow 2.06%. Sign up for live short interest data.
Nasdaq • EIKN • US2825641036
As of Oct 27, 2026, ORTEX estimated 18.2% of free float sold short, 11.7 days to cover, cost to borrow 2.06%. Sign up for live short interest data.
This page tracks how heavily Eikon Therapeutics (Nasdaq:EIKN) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Eikon Therapeutics (Nasdaq: EIKN) has a market capitalization of $331.49M. Last close $6.66 (as of 2026-11-12); 52-week range $5.01 to $17.40. ORTEX data as of 2026-10-27: short interest was 18.17% of free float, 11.7 days to cover and the average cost to borrow was 2.06%. Sign up for live short interest data.